# Phase 105 - Alpha Vantage Public Docs Gap Normalization

## Purpose

This document normalizes an additional externally produced Alpha Vantage
public-docs gap review into the deterministic repo documentation trail as
advisory verification material only.

The external review reportedly used official Alpha Vantage public sources where
possible and focused on what public documentation appears to answer versus
what remains unresolved before any future local snapshot review. Phase 105 does
not independently reopen those pages, call Alpha Vantage APIs, test endpoints,
download data, inspect observations, create local data files, add credentials,
add tests, add production behavior, or change any source, replay, broker,
advisory, governance, or runtime code.

The Perplexity output remains external advisory input. It is not legal review,
source approval, data approval, endpoint approval, universe approval,
return-construction approval, point-in-time proof, strategy validation, or
trading readiness.

## Normalization Boundary

Phase 105 may normalize Alpha Vantage public-doc gap findings only.

It must not approve:

- Alpha Vantage
- any Alpha Vantage endpoint
- any data source
- any data
- any ETF universe
- any benchmark
- any cash proxy
- any methodology
- any parameter set
- any evidence
- any return-construction policy
- any no-lookahead policy
- any cost/friction model
- any strategy validation
- any trading use

Reported public documentation, terms language, endpoint fields, symbol coverage
language, listing-status behavior, realtime or delayed market-data policy
language, and entitlement language are documentation leads only. They do not
approve Alpha Vantage source use, API use, endpoint use, local storage, local
snapshots, repo storage, fixtures, return construction, point-in-time
treatment, no-lookahead treatment, strategy validation, or trading use.

## Allowed Classification Vocabulary

Allowed `risk_level` values in this document are:

- `low_documented`
- `partially_documented`
- `unclear`
- `high_unresolved`

Allowed `allowed_next_step` values in this document are:

- `needs_repo_normalization`
- `needs_more_primary_docs`
- `needs_terms_review`
- `needs_support_question`
- `reject_for_now`

Forbidden `allowed_next_step` values are:

- `approved`
- `validated`
- `source_approved`
- `data_approved`
- `point_in_time_safe`
- `strategy_ready`
- `trading_ready`

The allowed values route later review only. They do not authorize Alpha
Vantage API calls, data downloads, local snapshots, fixture use, raw-row
storage, endpoint use, source use, universe membership, benchmark use, cash
proxy use, return construction, no-lookahead claims, scoring, ranking,
recommendation, strategy validation, or trading behavior.

## Normalized Public-Docs Gap Table

The table records public-doc findings as advisory gap-normalization context
only. Findings are normalized into repo language; they are not independently
proven by this phase.

| normalized_id | question_area | official_source_status | documented_answer_summary | unresolved_gap | support_question_needed | risk_level | allowed_next_step | non_claims |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| phase105_av_public_docs_endpoint_scope | Public docs endpoint coverage | Official Alpha Vantage API documentation reportedly answers some endpoint-shape questions. | Public docs reportedly identify time-series endpoints and fields enough to separate raw daily, adjusted daily, weekly adjusted, and monthly adjusted documentation leads. | Public docs do not prove ETF-specific completeness, rights, historical depth, correction behavior, or point-in-time safety. | Ask whether documented endpoint fields and availability apply consistently to ETFs, inactive symbols, premium plans, and historical access. | `partially_documented` | `needs_more_primary_docs` | Not endpoint approval; not source approval; not data approval. |
| phase105_av_terms_personal_commercial | Terms personal and commercial use | Official Terms of Service reportedly include personal non-commercial language and broad commercial-use language. | Personal non-commercial use reportedly exists unless otherwise agreed; commercial use may reportedly include research, testing, monitoring, or similar non-personal usage. | Public docs do not resolve whether private self-directed algorithmic research is personal or commercial, or whether paid-plan use changes rights. | Ask Alpha Vantage or legal counsel to classify private algorithmic research, testing, monitoring, and local storage under the Terms. | `high_unresolved` | `needs_terms_review` | Not legal approval; not storage approval; not research-use approval. |
| phase105_av_symbol_support_etf_mutual_fund | Stock, ETF, and mutual fund symbol support | Official search or global equity docs reportedly reference global stock, ETF, and mutual fund symbols. | ETFs are reportedly within the documented symbol-search or supported-symbol language. | Public docs do not resolve ETF coverage depth, histories to inception, symbol changes, closures, mergers, distribution detail, or survivorship-safe universe construction. | Ask whether ETF coverage includes complete active and delisted ETF price histories, symbol history continuity, and ETF-specific corporate-action handling. | `partially_documented` | `needs_support_question` | Not ETF universe approval; not ticker selection; not survivorship approval. |
| phase105_av_daily_raw_ohlcv | Raw daily OHLCV | Official API docs reportedly document a daily time-series endpoint returning raw open, high, low, close, and volume. | `TIME_SERIES_DAILY` reportedly returns raw daily OHLCV. | Public docs do not resolve ETF-specific availability, inactive-symbol availability, corrections, timestamp/as-of semantics, rights, or archival permission. | Ask whether raw daily ETF histories, including delisted ETFs, remain queryable and whether local archival is allowed. | `partially_documented` | `needs_support_question` | Not raw-price approval; not data approval; not local snapshot approval. |
| phase105_av_daily_adjusted_fields | Daily adjusted fields and entitlement | Official API docs reportedly document daily adjusted output; the external review reports `TIME_SERIES_DAILY_ADJUSTED` as premium. | Daily adjusted output reportedly includes raw OHLCV, adjusted close, split events, and dividend events; access may require premium entitlement. | Public docs do not resolve exact adjustment formula, ETF-specific distributions, adjusted OHLCV availability beyond raw OHLCV plus adjusted close, retroactive changes, or local research rights. | Ask whether adjusted data covers ETFs, what adjustment formula is used, whether adjusted OHLCV is available, what premium rights include, and how corrections are handled. | `partially_documented` | `needs_support_question` | Not adjusted-data approval; not total-return approval; not premium-use approval. |
| phase105_av_weekly_monthly_adjusted | Weekly/monthly adjusted fields | Official API docs reportedly document weekly and monthly adjusted endpoints. | Weekly and monthly adjusted endpoints reportedly include adjusted close and dividend fields. | Public docs do not resolve period availability timing, decision-date availability, total-return assumptions, ETF distributions, or revision behavior. | Ask when weekly/monthly adjusted values become final and whether prior values can change. | `partially_documented` | `needs_support_question` | Not return-construction approval; not no-lookahead approval. |
| phase105_av_realtime_delayed_policy | Realtime/delayed market-data policy and entitlements | Official market-data policy or entitlement documentation reportedly exists. | Public docs reportedly include realtime/delayed market-data policy or entitlement language. | Public docs do not resolve whether delayed or realtime policies affect historical daily snapshots, one-time bulk review, or repo storage. | Ask which plan and entitlement, if any, permits one-time ETF historical research snapshots and local retention. | `unclear` | `needs_terms_review` | Not entitlement approval; not API-use approval; not storage approval. |
| phase105_av_listing_status | Listing status active/delisted/date filtering | Official API docs reportedly document a `LISTING_STATUS` endpoint. | `LISTING_STATUS` reportedly supports active and delisted status plus date filtering for symbols, including ETFs. | Listing status does not prove delisted ETF price histories remain queryable indefinitely, solve survivorship-safe price history, or provide point-in-time universe membership with price data. | Ask whether listing-status output is point-in-time safe, whether historical delisted ETF prices remain available, and how symbol changes, mergers, and closures are represented. | `partially_documented` | `needs_support_question` | Not survivorship approval; not universe approval; not point-in-time safe. |
| phase105_av_license_storage_repo | License, archival, Git storage, and redistribution | Public Terms reportedly leave storage and redistribution questions unresolved. | Public docs do not appear to answer persistent local archival, private Git storage, public Git storage, shared examples, or derived-manifest restrictions. | Local raw-row archival, private repo storage, public repo storage, checksums, manifests, examples, publication, and redistribution remain unresolved. | Ask whether raw rows, derived metadata, manifests, checksums, and examples may be stored locally, in private Git, or in public repositories. | `high_unresolved` | `needs_terms_review` | Not repo-storage approval; not redistribution approval; not fixture approval. |
| phase105_av_etf_source_quality | ETF source-quality and survivorship gaps | Public docs reportedly identify ETF symbols but not ETF-specific data-quality guarantees. | ETF support is a documentation lead only. | ETF coverage depth, inception histories, delisted query retention, mergers, closures, symbol changes, ETF distributions, return of capital, capital gains distributions, special distributions, metadata, holdings, and profile support remain unresolved. | Ask Alpha Vantage to confirm ETF-specific coverage, corporate-action taxonomy, delisted retention, and survivorship-safe universe support. | `high_unresolved` | `needs_support_question` | Not ETF source-quality approval; not survivorship approval; not universe approval. |
| phase105_av_adjustment_pit_revision | Adjustment, point-in-time, and revisions | Public adjusted endpoint docs reportedly list fields but not all methodology and vintage details. | Public docs reportedly document adjusted close and dividend/split fields for some endpoints. | Exact adjusted close formula, reinvestment assumptions, adjustment factors, prior vintages, as-of metadata, correction policy, finalization timestamps, and retroactive adjusted-history changes remain unresolved. | Ask for adjustment formula, ETF distribution treatment, revision policy, vintage availability, and as-of/finalization metadata. | `high_unresolved` | `needs_support_question` | Not adjustment-methodology approval; not point-in-time proof; not no-lookahead approval. |
| phase105_av_bulk_snapshot_feasibility | One-time bulk ETF snapshot feasibility | Public docs reportedly leave exact plan and entitlement feasibility unresolved. | Public docs do not settle whether any plan supports a one-time bulk ETF snapshot with local retention. | Bulk collection rights, rate limits, premium entitlement scope, symbol coverage, storage, redistribution, and reproducibility remain unresolved. | Ask which plan, written permission, or contract is required before any one-time bulk ETF historical snapshot review. | `high_unresolved` | `needs_terms_review` | Not bulk-download approval; not local snapshot approval; not implementation approval. |
| phase105_av_candidate_disposition | Candidate disposition | Public docs answer some endpoint questions but leave controlling rights, ETF, PIT, and storage gaps. | Alpha Vantage remains unresolved and requires terms review, support questions, and more primary-doc review. | Source/data/legal/PIT/survivorship/storage questions remain unresolved. | Ask the support/legal questions before any future local snapshot review. | `high_unresolved` | `needs_support_question` | Not Alpha Vantage approval; not ingestion recommendation; not trading readiness. |

## Questions Answered By Public Docs

As advisory external findings only, Phase 105 records that public Alpha
Vantage docs reportedly answer or partially answer these questions:

- Personal non-commercial license language reportedly exists.
- Commercial-use language reportedly includes research, testing, monitoring,
  or similar activity beyond personal usage.
- ETFs are reportedly referenced as supported symbols through search or global
  equity documentation.
- A raw daily OHLCV endpoint reportedly exists.
- A daily adjusted endpoint reportedly includes raw OHLCV, adjusted close,
  split events, and dividend events.
- Weekly and monthly adjusted endpoints reportedly include adjusted close and
  dividend fields.
- `TIME_SERIES_DAILY_ADJUSTED` reportedly requires premium access.
- Realtime or delayed market-data policy and entitlement language reportedly
  exists.
- `LISTING_STATUS` reportedly supports active and delisted symbol status plus
  date filtering, including ETFs.

These findings are documentation leads only. They do not approve Alpha
Vantage, any endpoint, any source, any data, any local storage, any repo
storage, any local snapshot, any return construction, any universe, any
benchmark, any cash proxy, any strategy validation, or any trading use.

## Unresolved License And Storage Questions

Phase 105 records these unresolved license and storage questions:

- whether private self-directed algorithmic research is personal or commercial
- whether long-term local archival of raw rows is allowed
- whether raw data may be stored in private Git repositories
- whether any raw data may be stored in public repositories or shared examples
- whether derived metadata, manifests, or checksums are restricted
- whether premium plans grant broader local research rights
- whether legal review is needed before any local snapshot review

These questions are controlling blockers. No API call, download, raw-row
storage, fixture creation, local snapshot, private repo storage, public repo
storage, publication, redistribution, or normal-pytest dependency is approved
by this phase.

## Unresolved ETF And Source-Quality Questions

Phase 105 records these unresolved ETF and source-quality questions:

- ETF-specific coverage depth
- ETF histories to inception
- delisted ETF query retention
- ETF mergers, closures, and symbol changes
- ETF distributions, return of capital, capital gains distributions, and
  special distributions
- ETF metadata, holdings, and profile availability
- survivorship-safe ETF universe support

ETF symbol support in public docs is not enough for universe approval,
survivorship-safe price history, ETF ticker selection, benchmark selection,
cash proxy selection, strategy validation, or trading use.

## Unresolved Adjustment And Point-In-Time Questions

Phase 105 records these unresolved adjustment and point-in-time questions:

- exact adjusted close formula
- whether adjusted OHLCV is available or only adjusted close
- reinvestment or adjustment-factor assumptions
- revision and correction policy
- prior vintage or as-of access
- finalization timestamps or as-of metadata
- whether adjusted history can change retroactively
- no-lookahead risks

Adjusted endpoint field existence does not approve return construction,
total-return interpretation, dividend/distribution treatment, vintage
handling, no-lookahead modeling, or strategy validation.

## Candidate Disposition

Alpha Vantage disposition remains unresolved.

It is:

- not approved
- not rejected solely from this pass
- `needs_terms_review`
- `needs_support_question`
- `needs_more_primary_docs`

Phase 105 does not recommend ingestion, implementation, API calls, downloads,
fixtures, real data files, local snapshots, endpoint integration, source
approval, data approval, universe construction, return construction,
benchmark construction, cash proxy construction, strategy validation, or
trading use.

## Allowed Next Steps

Allowed next steps after Phase 105:

- draft Alpha Vantage support questions about terms, storage, redistribution,
  premium-plan rights, adjustment methodology, ETF distributions, revision
  policy, listing status, delisted ETF behavior, point-in-time behavior, and
  one-time bulk ETF snapshot feasibility
- terms and legal review
- additional official-document review
- no API calls yet
- no downloads
- no repo fixtures or data
- no implementation

Support questions should be drafted outside production code and outside normal
pytest. They should not include credentials or trigger network calls from repo
code.

## Relationship To Prior Phases

Phase 83 defined broad ETF source-path and local snapshot readiness criteria.
Phase 105 adds only advisory Alpha Vantage public-doc gap normalization. It
does not approve Alpha Vantage as a source path or local snapshot route.

Phase 88 defined return-basis and as-of interpretation boundaries. Alpha
Vantage endpoint existence and adjusted-data fields do not solve return
construction, adjusted-price interpretation, distribution treatment,
total-return construction, or no-lookahead timing.

Phase 89 defined universe, inception, and survivorship boundaries. Reported
ETF symbol support and listing status do not solve ETF universe approval,
inactive coverage, delisting treatment, symbol continuity, inception
eligibility, or survivorship-safe price history.

Phase 93 defined the broad ETF source evidence intake plan. Phase 105 remains
inside that framework and records external Alpha Vantage public-doc review as
advisory material only.

Phase 94 normalized earlier source-discovery output as advisory intake
material. Phase 105 continues that separation between scout/documentation
leads and approval.

Phase 95 normalized primary-source verification output for Stooq, Alpha
Vantage, and FRED. Phase 105 expands only the Alpha Vantage public-doc gap
portion and keeps Alpha Vantage unresolved.

Phase 104 normalized Alpha Vantage primary-source verification as advisory
material. Phase 105 is narrower: it records what public docs appear to answer,
what they do not resolve, and what support/legal questions are needed before
any future local snapshot review.

Across these phases:

- public docs do not approve source use
- endpoint existence does not approve data use
- listing status does not solve survivorship-safe price history
- adjusted data docs do not solve return construction
- terms do not yet approve local snapshots or repo storage
- Alpha Vantage data must not enter normal pytest through network calls or
  files

Normal `python -m pytest` must remain offline, credential-free, source-free,
vendor-free, and independent from Alpha Vantage.

## Explicit Non-Claims

Phase 105 is:

- not Alpha Vantage approval
- not endpoint approval
- not source approval
- not data approval
- not universe approval
- not benchmark approval
- not cash proxy approval
- not methodology approval
- not parameter approval
- not evidence approval
- not return-construction approval
- not no-lookahead approval
- not cost/friction approval
- not liquidity approval
- not strategy validation
- not trading readiness

It adds no Alpha Vantage approval, endpoint approval, source approval, data
approval, vendor approval, universe approval, benchmark approval, cash proxy
approval, methodology approval, parameter approval, evidence approval,
return-construction approval, no-lookahead approval, cost/friction approval,
liquidity approval, strategy validation, real data ingestion, raw external
data, local data file, Alpha Vantage API call, data download, credential,
ETF ticker selection, benchmark comparison, ranking, scoring, recommendation,
candidate discovery behavior in code, replay metric, manifest-to-planning
bridge, signal/evaluator behavior, broker/order/fill/portfolio/runtime
behavior, LLM call, network call, market-data call, dashboard/advisory/AI
integration, paper behavior, live behavior, or trading behavior.

## Decision

Decision: advisory Alpha Vantage public-doc gap normalization only.

Alpha Vantage remains unresolved. It is not approved and not rejected solely
from this pass. It requires terms review, support questions, and more
primary-document review before any future local snapshot review can be
considered.

No Alpha Vantage source use, endpoint use, API call, data use, local storage,
local snapshot, repo storage, fixture, ingestion, universe construction,
return construction, no-lookahead claim, strategy validation, or trading use
is approved.

No production code or tests changed. No real data was added. No Alpha Vantage
API calls or downloads occurred. Normal pytest remains offline and
credential-free.

## Remaining Blockers

- no approved Alpha Vantage use
- no approved endpoint
- no approved source
- no approved data
- no approved ETF universe
- no approved benchmark
- no approved cash proxy
- no approved methodology
- no approved parameter set
- no approved evidence
- no approved return-construction policy
- no approved no-lookahead/as-of policy
- no approved survivorship policy
- no approved listing-status policy
- no approved delisted ETF price-history retention policy
- no approved adjustment methodology
- no approved ETF dividend or distribution treatment
- no approved split treatment
- no approved total-return interpretation
- no approved revision or correction policy
- no approved vintage procedure
- no approved timestamp/as-of semantics
- no approved local snapshot
- no approved raw-row storage policy
- no approved private-repo storage policy
- no approved public-repo storage policy
- no approved redistribution policy
- no approved commercial/internal research policy
- no approved entitlement or premium-access policy
- no approved one-time bulk ETF snapshot feasibility
- no approved normal-pytest Alpha Vantage dependency
- no strategy-validation claim
- no trading-readiness claim

## Follow-Up Recommendation

The likely next step should be either drafting Alpha Vantage support questions
about the unresolved terms, storage, redistribution, premium-plan rights,
adjustment, revision, point-in-time, listing-status, delisted ETF, ETF
distribution, and one-time bulk snapshot gaps, or pausing Alpha Vantage and
reviewing another source if the unresolved terms, point-in-time, and
survivorship gaps are too large.
